Wed, Apr 16, 2014, 10:59 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Endo International plc Message Board

arnie4454 4 posts  |  Last Activity: Apr 4, 2014 7:30 PM Member since: Apr 8, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • The company seems to have gone nowhere in the 5 years Gerri has been running it with her family company Malvern Consulting Group. What a great way to increase her personal wealth, employ all sorts of family members and even have an IPO to keep getting paid. Where is the progress? Where is the data?

  • arnie4454 by arnie4454 Mar 15, 2014 3:04 PM Flag

    Wow Gerri is at it again. A brilliant charmer who can always make money for her family company, malvern consulting group, at the expense of others. She tanked Garnet Bio all the while putting money into the family fortunes. Recro has no new data and having an IPO is brilliant and hopefully others in addition to her family will benefit. Congratulations.

  • Reply to

    Clinical Data and Development

    by arnie4454 Mar 11, 2014 10:51 AM
    arnie4454 arnie4454 Mar 11, 2014 2:14 PM Flag

    Nonetheless, clinical evidence is required in order to be approved by FDA. A good reference would be Celsion's Thermodox, a liposomal encapsulation of doxorubicin, an approved and frequently used oncology drug for the treatment of a wide range of cancers. They failed in a pivotal clinical trial after spending tens of millions of dollars. Why, because the clinical evidence was not there compared to the control standard of care. CLSN.

  • Reply to

    Clinical Data and Development

    by arnie4454 Mar 11, 2014 10:51 AM
    arnie4454 arnie4454 Mar 11, 2014 11:27 AM Flag

    you wouldn't know clinical evidence if it was right in front of you. do you know what reproducibility means? without this there is nothing.

57.70+1.42(+2.52%)Apr 16 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Google Inc.
NasdaqGSWed, Apr 16, 2014 4:00 PM EDT